ROCKVILLE, Md., A recently released research report by Fact.MR, a market research and competitive intelligence provider, states that the global heart valve repair and replacement market is poised for significant growth, with projections indicating an increase from US$ 8,548.5 million in 2024 to US$ 22,252.4 million by 2034, reflecting a robust CAGR of 10% over the forecast period.

The increasing prevalence of cardiovascular diseases, particularly among the aging population, is a primary driver of the heart valve repair and replacement market. Sedentary lifestyles, physical inactivity, and other habits such as smoking have induced the prevalence of cardiovascular diseases, subsequently increasing the demand for minimally invasive procedures to address cardiac anomalies.

Technological advancements have led to the development of less invasive procedures, such as Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral Valve Repair (TMVR), offering alternatives to traditional open-heart surgeries. These innovations have expanded the patient pool eligible for valve interventions, including those at higher surgical risk.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9413

Key Takeaway from Market Study:

• The global heart valve repair and replacement market is forecasted to expand at a CAGR of 10.0% from 2024 to 2034.
• The North American market for heart valve repair and replacement is forecasted to expand at a CAGR of 9.9% through 2034.
• The Chinese heart valve repair and replacement industry is estimated to be worth US$ 434 million in 2024.
• The East Asian heart valve repair and replacement market is anticipated to exhibit substantial progress, aiming for a 10.4% CAGR through 2034.
• The transcatheter aortic valve implantation segment is expected to account for 72.90% of the global heart valve repair and replacement market in 2024.

“Market players should invest in advanced technologies, awareness campaigns, and affordable treatment options to overcome cost constraints, limited healthcare infrastructure, and lack of awareness, ensuring broader accessibility and sustained growth in the heart valve repair and replacement market,” says a Fact.MR analyst.

Growing Adoption of TAVI for Minimally Invasive Heart Valve Replacement

Transcatheter aortic valve implantation (TAVI) is rapidly gaining traction due to its minimally invasive approach compared to open-heart surgery. It offers reduced recovery time and fewer complications, making it ideal for elderly patients and those at high surgical risk. TAVI is increasingly preferred for individual’s ineligible for traditional valve replacement. Advances in catheter-based technologies and imaging techniques have further enhanced the precision and success rates of TAVI procedures, solidifying its role as a key solution in cardiovascular disease management.

Key Market Players:

• Abbott
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• CryoLife, Inc.
• LivaNova PLC
• Colibri Heart Valve
• JenaValve Technology, Inc.
• Micro Interventional Devices, Inc.
• Braile Biomedica
• Arbor Surgical Technologies, Inc.
• Aortech International Plc

Competitive Landscape

The global heart valve repair and replacement market is highly competitive, with several international players leading the industry. Major companies like Abbott, Edwards Lifesciences Corporation, Boston Scientific Corporation, and CryoLife Inc. dominate the market, often partnering with hospital and surgical chains to supply advanced technologies. Smaller firms also contribute, leveraging innovations from larger companies’ R&D efforts.

Recent Developments:

• July 2, 2023: PGI Chandigarh became the first hospital in North India to perform transfemoral transseptal mitral valve replacement (TMVR), a complex minimally invasive procedure.
• May 8, 2023: Aster Medcity launched the Aster Advanced Heart Valve Centre under Aster Cardiac Sciences, dedicated to valvular heart disease diagnosis and treatment.

TruLeaf Medical (Israel) developed the RoseDoc platform, enabling minimally invasive heart valve replacement on a beating heart using two needle punctures, eliminating the need for surgery.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=9413

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the heart valve repair and replacement market, presenting historical demand data and forecast statistics for the period (2024 to 2034).

The heart valve repair and replacement market is segmented based on product, indication, end user, and region. By product, it includes heart valve repair, replacement, tissue heart valves, and transcatheter aortic valve implantation (TAVI). Indications covered are aortic stenosis, aortic regurgitation, mitral stenosis, and mitral regurgitation. Key end users are hospitals, ambulatory surgical centers, and cardiac catheterization laboratories. Geographically, the market spans North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA), reflecting a global demand for advanced cardiovascular treatments.

Check out More Related Studies Published by Fact.MR Research:

Heart valve devices market is expected to grow at a 13% CAGR and reach $37.5 Billion by 2032. Transcatheter heart valve devices to dominate the market.

Structural heart devices market is expected to increase from a valuation of $12.17 billion in 2023 to $36.06 billion by 2033-end.

Transcatheter heart valve replacement market is estimated at $5.31 billion in 2024 and is projected to rise at a CAGR of 13.9% to reach $19.43 billion by the end of 2034.

Fetal and neonatal heart monitor market is expected to reach $8.9 billion in 2023 and grow at a CAGR of 5.5% to reach $15.2 billion by 2033.

Heart monitoring devices market is projected to reach $45 billion by 2033. Worldwide demand for heart monitoring devices is forecasted to increase at a CAGR of 6% from 2023 to 2033.

Heart attack diagnostics market is estimated to reach a value of nearly $23.8 Billion by 2033 growing from $12 Billion in 2023.